等待開盤 12-23 09:30:00 美东时间
-1.430
-0.23%
Morgan Stanley analyst Angel Castillo maintains Martin Marietta Materials (NYSE:MLM) with a Overweight and raises the price target from $660 to $690.
今天 01:41
今日重点评级关注:HC Wainwright & Co.:维持BioCryst Pharma"买入"评级,目标价从30美元升至32美元;TD Cowen:上调Milestone Pharmaceuticals评级至"买入",目标价8美元
12-16 09:36
Jefferies analyst Philip Ng maintained a Buy rating on Martin Marietta Material...
12-15 17:46
PITTSBURGH, Dec. 8, 2025 /PRNewswire/ -- WESCO International, Inc. (NYSE: WCC), a leading provider of business-to-business distribution, logistics services, and supply chain solutions, today...
12-08 20:20
今日重点评级关注:RBC Capital:上调Neumora Therapeutics评级至"跑赢大市",目标价从4美元升至7美元;HC Wainwright & Co.:维持ProMIS Neurosciences"买入"评级,目标价从4美元升至18美元
12-02 09:50
Morgan Stanley analyst Angel Castillo maintains Martin Marietta Materials (NYSE:MLM) with a Overweight and raises the price target from $610 to $660.
12-02 02:06
Martin Marietta Materials Inc's (NYSE:MLM) short interest as a percent of float...
11-25 01:00
<p>Martin Marietta Materials, Inc. announced a regular quarterly cash dividend of $0.83 per share, payable on December 31, 2025, to shareholders of record on December 1, 2025. The company, a leading supplier of aggregates and heavy building materials, operates across 28 U.S. states, Canada, and The Bahamas. For more details, visit the company's website or contact Investor Relations.</p>
11-13 21:26
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
11-12 11:43
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
11-10 17:17